The Health Service Products (Provision and Disclosure of Information) Regulations 2018

Transitional provision: information about supply of unbranded generic health service medicines U.K.

2.—(1) A Scheme member is not required to comply—

(a) with regulation 7 or 8 in any month which falls within a transitional quarter, or

(b) with regulation 9 in respect of any transitional quarter.

(2) But this paragraph is subject to paragraph 3.

(3) In this paragraph and paragraph 3—

“Scheme end date” means—

(a)

in the case of a member of Scheme M, the day on which Scheme M ceases to operate following notice of termination being given by the Secretary of State in accordance with that Scheme;

(b)

in the case of a member of Scheme W, the day on which Scheme W ceases to operate following notice of termination being given by the Secretary of State in accordance with that Scheme;

“Scheme member” means a UK producer who, immediately before 1st July 2018, is a member of Scheme M or Scheme W;

“transitional quarter” means a quarterly period (as determined in accordance with regulation 9(2)) which—

(a)

begins on or after 1st July 2018, but

(b)

before the Scheme end date.

(4) For the purposes of this paragraph, it does not matter whether the Secretary of State gives notice of termination in accordance with Scheme M or Scheme W before, on or after 1st July 2018.